Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

NASDAQ:CVRX - Nasdaq - US1266381052 - Common Stock - Currency: USD

13.85  -0.16 (-1.14%)

Premarket: 14.5 +0.65 (+4.69%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CVRX. CVRX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. CVRX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CVRX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CVRX has reported negative net income.
CVRX had a negative operating cash flow in the past year.
CVRX had negative earnings in each of the past 5 years.
CVRX had a negative operating cash flow in each of the past 5 years.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

CVRX has a Return On Assets of -45.80%. This is in the lower half of the industry: CVRX underperforms 65.78% of its industry peers.
With a Return On Equity value of -89.71%, CVRX is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -45.8%
ROE -89.71%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

With an excellent Gross Margin value of 84.16%, CVRX belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
CVRX's Gross Margin has improved in the last couple of years.
CVRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVRX has been increased compared to 1 year ago.
The number of shares outstanding for CVRX has been increased compared to 5 years ago.
Compared to 1 year ago, CVRX has a worse debt to assets ratio.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CVRX has an Altman-Z score of -2.50. This is a bad value and indicates that CVRX is not financially healthy and even has some risk of bankruptcy.
CVRX has a worse Altman-Z score (-2.50) than 63.64% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that CVRX is somewhat dependend on debt financing.
CVRX's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. CVRX is outperformed by 73.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z -2.5
ROIC/WACCN/A
WACC9%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CVRX has a Current Ratio of 11.32. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
CVRX has a better Current ratio (11.32) than 94.65% of its industry peers.
CVRX has a Quick Ratio of 10.23. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CVRX (10.23) is better than 94.65% of its industry peers.
Industry RankSector Rank
Current Ratio 11.32
Quick Ratio 10.23
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

CVRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.86%.
The Revenue has grown by 30.53% in the past year. This is a very strong growth!
Measured over the past years, CVRX shows a very strong growth in Revenue. The Revenue has been growing by 52.30% on average per year.
EPS 1Y (TTM)-35.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.27%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%35.71%

3.2 Future

The Earnings Per Share is expected to grow by 12.33% on average over the next years. This is quite good.
CVRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.46% yearly.
EPS Next Y24.22%
EPS Next 2Y16.21%
EPS Next 3Y12.33%
EPS Next 5YN/A
Revenue Next Year25.67%
Revenue Next 2Y25.77%
Revenue Next 3Y25.46%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CVRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as CVRX's earnings are expected to grow with 12.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.21%
EPS Next 3Y12.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CVRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CVRX INC

NASDAQ:CVRX (2/21/2025, 8:11:26 PM)

Premarket: 14.5 +0.65 (+4.69%)

13.85

-0.16 (-1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)04-28 2025-04-28/amc
Inst Owners67.49%
Inst Owner Change-84.52%
Ins Owners4.21%
Ins Owner Change0%
Market Cap350.68M
Analysts81.54
Price Target21.22 (53.21%)
Short Float %7.98%
Short Ratio8.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.97%
Min EPS beat(2)-19.26%
Max EPS beat(2)-16.68%
EPS beat(4)1
Avg EPS beat(4)-25.91%
Min EPS beat(4)-88.53%
Max EPS beat(4)20.82%
EPS beat(8)5
Avg EPS beat(8)-7%
EPS beat(12)8
Avg EPS beat(12)-4.38%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.28%
Min Revenue beat(2)-1.79%
Max Revenue beat(2)-0.76%
Revenue beat(4)0
Avg Revenue beat(4)-2.63%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)-0.55%
Revenue beat(8)4
Avg Revenue beat(8)1.56%
Revenue beat(12)7
Avg Revenue beat(12)1.89%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.5%
PT rev (3m)50.72%
EPS NQ rev (1m)3.31%
EPS NQ rev (3m)3.31%
EPS NY rev (1m)3.02%
EPS NY rev (3m)6.52%
Revenue NQ rev (1m)1.4%
Revenue NQ rev (3m)1.4%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.42
P/FCF N/A
P/OCF N/A
P/B 5.38
P/tB 5.38
EV/EBITDA N/A
EPS(TTM)-2.69
EYN/A
EPS(NY)-2.04
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)-1.54
OCFYN/A
SpS1.87
BVpS2.57
TBVpS2.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.8%
ROE -89.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.16%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 258.29%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.32
Quick Ratio 10.23
Altman-Z -2.5
F-Score3
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.27%
EPS Next Y24.22%
EPS Next 2Y16.21%
EPS Next 3Y12.33%
EPS Next 5YN/A
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%35.71%
Revenue Next Year25.67%
Revenue Next 2Y25.77%
Revenue Next 3Y25.46%
Revenue Next 5YN/A
EBIT growth 1Y-31.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.24%
OCF growth 3YN/A
OCF growth 5YN/A